arrow
H

Hirofumi Ochi

ehime university
H指数:28
被引数:2,472

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Long-term effectiveness and safety of satralizumab for neuromyelitis optica spectrum disorder in a real-world clinical setting in Japan: A 2.5-year final analysis of a multicenter medical chart review (The SAkuraBeyond Study)

日本真实世界临床环境中视神经脊髓炎谱系障碍患者应用萨他利珠单抗的长期有效性与安全性:一项多中心医疗病历回顾的2.5年最终分析(The SAkuraBeyond Study)

2026-02-240
PRE
A multicenter, retrospective study in patients with multiple sclerosis treated with natalizumab in a real-world setting in Japan: the REFIND study
2026-01-150
OAAI
Safety and Effectiveness of Dimethyl Fumarate in Japanese Patients With Multiple Sclerosis: 2-Year Post-Marketing Surveillance Data

富马酸二甲酯在日本多发性硬化患者中的安全性与有效性:上市后2年监测数据

2025-12-010
OAAI
HLA genotype-clinical phenotype correlations in multiple sclerosis and neuromyelitis optica spectrum disorders based on Japan MS/NMOSD Biobank data

基于日本MS/NMOSD生物库数据的多发性硬化症和视神经脊髓炎谱系障碍的HLA基因型-临床表型相关性

2021-01-1227
OAAI
Altered features of monocytes in adult onset leukoencephalopathy with axonal spheroids and pigmented glia: A clue to the pathomechanism of microglial dyshomeostasis

伴有轴突球体和色素胶质的成人白质脑病中单核细胞的改变特征: 小胶质细胞失调的病理机制的线索

2020-07-017
OAAI
Signaling via toll-like receptor 4 and CD40 in B cells plays a regulatory role in the pathogenesis of multiple sclerosis through interleukin-10 production

B细胞中toll样受体4和CD40的信号传导通过interleukin-10产生在多发性硬化的发病机理中起调节作用

2018-03-0140
OA